These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Lessons from MATCH for future randomised trials in secondary prevention of stroke. Rothwell PM. Lancet; ; 364(9431):305-7. PubMed ID: 15276368 [No Abstract] [Full Text] [Related]
5. Role of aspirin in MATCH. Bath P. Lancet; ; 364(9446):1662; author reply 1662-3. PubMed ID: 15530618 [No Abstract] [Full Text] [Related]
6. [Secondary prevention of TIA and stroke. How much must thrombocytes not be inhibited?]. Einecke D. MMW Fortschr Med; 2004 Jun 10; 146(24):50. PubMed ID: 15366495 [No Abstract] [Full Text] [Related]
13. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel. Prescrire Int; 2009 Oct 10; 18(103):193-5. PubMed ID: 19877380 [Abstract] [Full Text] [Related]
15. Dual antiplatelet therapy in stroke and ICAS: Subgroup analysis of CHANCE. Liu L, Wong KS, Leng X, Pu Y, Wang Y, Jing J, Zou X, Pan Y, Wang A, Meng X, Wang C, Zhao X, Soo Y, Johnston SC, Wang Y, CHANCE Investigators. Neurology; 2015 Sep 29; 85(13):1154-62. PubMed ID: 26330567 [Abstract] [Full Text] [Related]
16. Dual antiplatelet therapy for secondary stroke prevention: Use of clopidogrel and acetylsalicylic acid after noncardioembolic ischemic stroke. Koziol K, Van der Merwe V, Yakiwchuk E, Kosar L. Can Fam Physician; 2016 Aug 29; 62(8):640-5. PubMed ID: 27521393 [No Abstract] [Full Text] [Related]
18. Combined clopidogrel-aspirin treatment for high risk TIA or minor stroke does not increase cerebral microbleeds. Wang Z, Xu C, Wang P, Wang Y, Xin H. Neurol Res; 2015 Nov 29; 37(11):993-7. PubMed ID: 26391570 [Abstract] [Full Text] [Related]